These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7647004)

  • 1. CD3-induced T-cell activation in the bone marrow of myeloma patients: major role of CD4+ cells.
    Bianchi A; Montacchini L; Barral P; Borrione P; Attisano C; Orsini E; Boccadoro M; Pileri A; Massaia M
    Br J Haematol; 1995 Jul; 90(3):625-32. PubMed ID: 7647004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid generation of antiplasma cell activity in the bone marrow of myeloma patients by CD3-activated T cells.
    Massaia M; Attisano C; Peola S; Montacchini L; Omedé P; Corradini P; Ferrero D; Boccadoro M; Bianchi A; Pileri A
    Blood; 1993 Sep; 82(6):1787-97. PubMed ID: 8400233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of T-cell subsets in the response to anti-CD3 monoclonal antibodies.
    Finck BK; Yung CM; Carteron NL; Wofsy D
    Clin Immunol Immunopathol; 1992 Dec; 65(3):234-41. PubMed ID: 1360341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex.
    Massaia M; Bianchi A; Attisano C; Peola S; Redoglia V; Dianzani U; Pileri A
    Blood; 1991 Oct; 78(7):1770-80. PubMed ID: 1832993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costimulation of CD4+ and CD8+ T cells through CD26: the ADA-binding epitope is not essential for complete signaling.
    De Meester IA; Kestens LL; Vanham GL; Vanhoof GC; Vingerhoets JH; Gigase PL; Scharpé SL
    J Leukoc Biol; 1995 Sep; 58(3):325-30. PubMed ID: 7665988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of CD4 and CD8 engagement on the development of cytokine profiles of murine CD4+ and CD8+ T lymphocytes.
    Campbell SB; Komata T; Kelso A
    Immunology; 2000 Mar; 99(3):394-401. PubMed ID: 10712669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and immunological studies in advanced cancer patients sequentially treated with anti CD3 monoclonal antibody (OKT3) and interleukin-2.
    Borrione P; Montacchini L; Beggiato E; Pileri A; Bianchi A; Massaia M
    Leuk Lymphoma; 1996 Apr; 21(3-4):325-30. PubMed ID: 8726415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
    Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of antigen-specific responses using in vitro enriched T cells.
    Jones N; Agrawal D; Elrefaei M; Hanson A; Novitsky V; Wong JT; Cao H
    J Immunol Methods; 2003 Mar; 274(1-2):139-47. PubMed ID: 12609540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and phenotypic properties of peripheral T cells anergized by autologous CD3(+) depleted bone marrow cells.
    Jin Y; Fuller L; Carreno M; Esquenazi V; Blomberg BB; Wei YT; Ciancio G; Burke GW; Tzakis A; Ricordi C; Miller J
    Hum Immunol; 2002 Jul; 63(7):567-75. PubMed ID: 12072192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.
    Yang W; Hussain S; Mi QS; Santamaria P; Delovitch TL
    J Immunol; 2004 Oct; 173(7):4407-16. PubMed ID: 15383571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of anti-tumour activity by OKT3-stimulation in multiple myeloma: in vitro inhibition of autologous haemopoiesis.
    Attisano C; Bianchi A; Montacchini L; Carlesso N; Peola S; Bruno B; Roux V; Ferrero D; Gallo E; Boccadoro M
    Br J Haematol; 1994 Jul; 87(3):494-502. PubMed ID: 7993789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation.
    Tohma S; Hirohata S; Lipsky PE
    J Immunol; 1991 Jan; 146(2):492-9. PubMed ID: 1670945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
    Damle NK; Doyle LV
    J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of CD4+ cytotoxic T lymphocytes stimulated by immobilized anti-CD3 monoclonal antibody and interleukin-2 in cancer patients.
    Tani M; Tanimura H; Yamaue H; Mizobata S; Iwahashi M; Tsunoda T; Noguchi K; Tamai M; Hotta T; Terasawa H
    Int J Cancer; 1995 Mar; 60(6):802-7. PubMed ID: 7896449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor induction of interleukin-2 receptor expression on CD8bright+ cells in whole blood cell cultures with CD3 mAb. Implications for immunotherapy with CD3 mAb.
    Janssen RA; Heijn AA; The TH; de Leij L
    Cancer Immunol Immunother; 1994 Jan; 38(1):53-60. PubMed ID: 8299119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden.
    Feyler S; von Lilienfeld-Toal M; Jarmin S; Marles L; Rawstron A; Ashcroft AJ; Owen RG; Selby PJ; Cook G
    Br J Haematol; 2009 Mar; 144(5):686-95. PubMed ID: 19133978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
    J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferons alpha/beta inhibit IL-7-induced proliferation of CD4- CD8- CD3- CD44+ CD25+ thymocytes, but do not inhibit that of CD4- CD8- CD3- CD44- CD25- thymocytes.
    Su DM; Wang J; Lin Q; Cooper MD; Watanabe T
    Immunology; 1997 Apr; 90(4):543-9. PubMed ID: 9176107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.